The abstract is read at the publisher; the summary is JClub's.
High serum chitotriosidase (CHIT1) is linked to TSPO-PET–measurable glial activation at chronic active lesion rims in people with multiple sclerosis, with CHIT1-high defined by 22.1 ng/ml.
- Why it matters: The study addresses whether a blood marker can reflect PET-detected glial activation in MS, targeting chronic active lesion edge pathology that may be missed by conventional measures.
- What they did: In a cross-sectional cohort of 89 pwMS (19 progressive, 70 relapsing-remitting) and 16 matched healthy controls, CHIT1 was quantified by ELISA and correlated with [11C]PK11195 TSPO-PET across rim-active lesion metrics and perilesional TSPO binding.
- The result: CHIT1 correlated with rim-active lesion number (r=0.33, p=0.038), volume (r=0.39, p=0.013), and percentage (r=0.31, p=0.046), and with perilesional TSPO binding (r=0.36, p=0.020) in the CHIT1-high exploratory subgroup.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.